Key result
Preclinical research on angiotensinogen antisense oligonucleotides suggests potential new therapeutics for hypertension and provides insights into the physiological roles of angiotensinogen.
Preclinical studies suggest AGT ASOs could be a promising new therapeutic strategy for hypertension.
No takes yet. Share an insight, caveat, or question.
May guide angiotensinogen ASO development for hypertension; leaves open translation to human trials.
Wu et al. (2018) conducted a review in Hypertension and other diseases. Angiotensinogen antisense oligonucleotides (ASOs) was evaluated. Preclinical research on angiotensinogen antisense oligonucleotides suggests potential new therapeutics for hypertension and provides insights into the physiological roles of angiotensinogen.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: